Sean Cao

Corporate Officer/Principal at NOVABRIDGE BIOSCIENCES

Net worth: 29 730 $ as of 30/06/2026

59 year

85 connections

Health Technology

Consumer Services

Finance

Profile

Sean Wuxiong Cao was the founder of Everest Medicines Ltd., founded in 2017, where the title held was CEO from 2017 to 2020.
Dr. Cao is also the founder of Abio-X Holdings, Inc...
Current jobs include Managing Director at CBC Group (Singapore) Pte.
Ltd. since 2016, Director at NiKang Therapeutics, Inc., and Chief Business Development Officer at NovaBridge Biosciences starting in 2026.
Former jobs include Chief Executive Officer & Director at ENSEM Therapeutics, Inc., Director at Aureon Biosciences, Inc. from 2009 to 2010, Manager-Product Development at Johnson & Johnson in 2008, Associate at New Leaf Venture Partners LLC from 2008 to 2009, and Senior Research Investigator at Sanofi-Aventis U.S.
LLC from 2001 to 2004.
Education includes an MBA from the University of Pennsylvania, a doctorate from Nankai University, and a doctorate from the University of Virginia conferred in 1990.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NOVABRIDGE BIOSCIENCES 0.02%	22/06/2026	35,073 ( 0.02% )	29 730 $	30/06/2026

Sean Cao active positions

Companies	Position	Start
NOVABRIDGE BIOSCIENCES	Corporate Officer/Principal	03/09/2025
NiKang Therapeutics, Inc. NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients	Director/Board Member	-
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Director/Board Member	01/10/2016
Abio-X Holdings, Inc.	Chief Executive Officer	-

All active positions of Sean Cao

Former positions of Sean Cao

Companies	Position	End
ENSEM Therapeutics, Inc. ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology	Chief Executive Officer	05/06/2023
EVEREST MEDICINES LIMITED	Chief Executive Officer	01/02/2020
Aureon Biosciences, Inc. Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services	Director/Board Member	01/03/2010
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Private Equity Analyst	01/09/2009
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Private Equity Analyst	31/08/2009

See the detail of Sean Cao's experience

Training of Sean Cao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sean Cao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Aureon Biosciences, Inc. Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services	Health Technology
University of Virginia University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Finance
Nankai University Nankai University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services	Health Technology
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Finance
Everest Medicines Ltd. Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs	Health Technology
I-Mab I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases	Health Technology
NiKang Therapeutics, Inc. NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients	Health Technology
ENSEM Therapeutics, Inc. ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology	Health Technology
Abio-X Holdings, Inc.